Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627367 · ClinicalTrials.gov registry record · Phase 3
Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain
A Phase 3 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
NCT00627367 is a Phase 3 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 224 participants.
The verdict
NCT00627367, a Phase 3 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
Study Summary
Patients treated with protocolized pain management (1 mg of IV hydromorphone followed by an additional 1 mg IV hydromorphone if the patient wants more) will have better pain relief and no more adverse events than patients receiving non-protocolized pain management.
Interventions
- DRUG Hydromorphone
- DRUG Nonprotocolized
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627367
The ClinicalTrials.gov registry entry for NCT00627367 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT00627367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627367 about?
NCT00627367 is a clinical study titled "Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain". Patients treated with protocolized pain management (1 mg of IV hydromorphone followed by an additional 1 mg IV hydromorphone if the patient wants more) will have better pain relief and no more adverse events than patients receiving non-protocolized pain management.
What is the current status of trial NCT00627367?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2007-12. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00627367?
The interventions under investigation include: Hydromorphone (DRUG), Nonprotocolized (DRUG).
Who is sponsoring clinical trial NCT00627367?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.